Facial Injectable Market Size, Share & Trends Report

Facial Injectable Market Size, Share & Trends Analysis Report By Product (Collagen & PMMA Microspheres, Hyaluronic Acid), By Application (Facial Line Correction, Face Lift), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-1-68038-849-7
Number of Report Pages: 172
Format: PDF, Horizon Databook

Historical Range: 2018 - 2021
Forecast Period: 2023 - 2030
Industry: Healthcare

Market Segmentation

Facial Injectable Product Outlook (Revenue, USD Billion, 2018 - 2030)
- Collagen & PMMA Microspheres
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Poly-L-lactic Acid (PLLA)
- Others
Facial Injectable Application Outlook (Revenue, USD Billion, 2018 - 2030)
- Facial Line Correction
- Lip Augmentation
- Face Lift
- Acne Scar Treatment
- Lipoatrophy Treatment
- Others
Facial Injectable End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- MedSpas
- Dermatology Clinics
- Hospitals
Facial Injectable Regional Outlook (Revenue, USD Billion, 2018 - 2030)
- North America
  - North America Facial Injectable Market, By Product
    - Collagen & PMMA Microspheres
    - Hyaluronic Acid (HA)
    - Botulinum Toxin Type A
    - Calcium Hydroxylapatite (CaHA)
    - Poly-L-lactic Acid (PLLA)
    - Others
  - North America Facial Injectable Market, By Application
    - Facial Line Correction
    - Lip Augmentation
    - Face Lift
    - Acne Scar Treatment
    - Lipoatrophy Treatment
    - Others
  - North America Facial Injectable Market, By End-use
    - MedSpas
    - Dermatology Clinics
    - Hospitals
  - U.S.
    - U.S. Facial Injectable Market, By Product
      - Collagen & PMMA Microspheres
      - Hyaluronic Acid (HA)
      - Botulinum Toxin Type A
      - Calcium Hydroxylapatite (CaHA)
      - Poly-L-lactic Acid (PLLA)
      - Others
    - U.S. Facial Injectable Market, By Application
      - Facial Line Correction
      - Lip Augmentation
      - Face Lift
      - Acne Scar Treatment
      - Lipoatrophy Treatment
      - Others
    - U.S. Facial Injectable Market, By End-use
      - MedSpas
      - Dermatology Clinics
      - Hospitals
  - Canada
    - Canada Facial Injectable Market, By Product
      - Collagen & PMMA Microspheres
      - Hyaluronic Acid (HA)
      - Botulinum Toxin Type A
      - Calcium Hydroxylapatite (CaHA)
      - Poly-L-lactic Acid (PLLA)
      - Others
    - Canada Facial Injectable Market, By Application
      - Facial Line Correction
      - Lip Augmentation
      - Face Lift
      - Acne Scar Treatment
      - Lipoatrophy Treatment
      - Others
    - Canada Facial Injectable Market, By End-use
      - MedSpas
      - Dermatology Clinics
      - Hospitals
- Europe
  - Europe Facial Injectable Market, By Product
    - Collagen & PMMA Microspheres
    - Hyaluronic Acid (HA)
    - Botulinum Toxin Type A
    - Calcium Hydroxylapatite (CaHA)
    - Poly-L-lactic Acid (PLLA)
    - Others
  - Europe Facial Injectable Market, By Application
    - Facial Line Correction
    - Lip Augmentation
    - Face Lift
    - Acne Scar Treatment
    - Lipoatrophy Treatment
    - Others
  - Europe Facial Injectable Market, By End-use
    - MedSpas
    - Dermatology Clinics
    - Hospitals
  - UK
    - UK Facial Injectable Market, By Product
      - Collagen & PMMA Microspheres
      - Hyaluronic Acid (HA)
      - Botulinum Toxin Type A
      - Calcium Hydroxylapatite (CaHA)
      - Poly-L-lactic Acid (PLLA)
      - Others
    - UK Facial Injectable Market, By Application
      - Facial Line Correction
      - Lip Augmentation
      - Face Lift
      - Acne Scar Treatment
      - Lipoatrophy Treatment
      - Others
    - UK Facial Injectable Market, By End-use
      - MedSpas
      - Dermatology Clinics
      - Hospitals
  - Germany
    - Germany Facial Injectable Market, By Product
      - Collagen & PMMA Microspheres
      - Hyaluronic Acid (HA)
      - Botulinum Toxin Type A
      - Calcium Hydroxylapatite (CaHA)
      - Poly-L-lactic Acid (PLLA)
      - Others
    - Germany Facial Injectable Market, By Application
      - Facial Line Correction
      - Lip Augmentation
      - Face Lift
      - Acne Scar Treatment
      - Lipoatrophy Treatment
      - Others
    - Germany Facial Injectable Market, By End-use
      - MedSpas
      - Dermatology Clinics
      - Hospitals
  - France
    - France Facial Injectable Market, By Product
      - Collagen & PMMA Microspheres
      - Hyaluronic Acid (HA)
      - Botulinum Toxin Type A
      - Calcium Hydroxylapatite (CaHA)
      - Poly-L-lactic Acid (PLLA)
      - Others
    - France Facial Injectable Market, By Application
      - Facial Line Correction
      - Lip Augmentation
      - Face Lift
      - Acne Scar Treatment
      - Lipoatrophy Treatment
      - Others
    - France Facial Injectable Market, By End-use
      - MedSpas
      - Dermatology Clinics
      - Hospitals
  - Italy
    - Italy Facial Injectable Market, By Product
      - Collagen & PMMA Microspheres
      - Hyaluronic Acid (HA)
      - Botulinum Toxin Type A
      - Calcium Hydroxylapatite (CaHA)
      - Poly-L-lactic Acid (PLLA)
      - Others
    - Italy Facial Injectable Market, By Application
      - Facial Line Correction
      - Lip Augmentation
      - Face Lift
      - Acne Scar Treatment
      - Lipoatrophy Treatment
      - Others
    - Italy Facial Injectable Market, By End-use
      - MedSpas
      - Dermatology Clinics
      - Hospitals
  - Spain
    - Spain Facial Injectable Market, By Product
      - Collagen & PMMA Microspheres
      - Hyaluronic Acid (HA)
      - Botulinum Toxin Type A
      - Calcium Hydroxylapatite (CaHA)
      - Poly-L-lactic Acid (PLLA)
      - Others
    - Spain Facial Injectable Market, By Application
      - Facial Line Correction
      - Lip Augmentation
      - Face Lift
      - Acne Scar Treatment
      - Lipoatrophy Treatment
      - Others
    - Spain Facial Injectable Market, By End-use
      - MedSpas
      - Dermatology Clinics
      - Hospitals
  - Denmark
    - Denmark Facial Injectable Market, By Product
      - Collagen & PMMA Microspheres
      - Hyaluronic Acid (HA)
      - Botulinum Toxin Type A
      - Calcium Hydroxylapatite (CaHA)
      - Poly-L-lactic Acid (PLLA)
      - Others
    - Denmark Facial Injectable Market, By Application
      - Facial Line Correction
      - Lip Augmentation
      - Face Lift
      - Acne Scar Treatment
      - Lipoatrophy Treatment
      - Others
    - Denmark Facial Injectable Market, By End-use
      - MedSpas
      - Dermatology Clinics
      - Hospitals
  - Sweden
    - Sweden Facial Injectable Market, By Product
      - Collagen & PMMA Microspheres
      - Hyaluronic Acid (HA)
      - Botulinum Toxin Type A
      - Calcium Hydroxylapatite (CaHA)
      - Poly-L-lactic Acid (PLLA)
      - Others
    - Sweden Facial Injectable Market, By Application
      - Facial Line Correction
      - Lip Augmentation
      - Face Lift
      - Acne Scar Treatment
      - Lipoatrophy Treatment
      - Others
    - Sweden Facial Injectable Market, By End-use
      - MedSpas
      - Dermatology Clinics
      - Hospitals
  - Norway
    - Norway Facial Injectable Market, By Product
      - Collagen & PMMA Microspheres
      - Hyaluronic Acid (HA)
      - Botulinum Toxin Type A
      - Calcium Hydroxylapatite (CaHA)
      - Poly-L-lactic Acid (PLLA)
      - Others
    - Norway Facial Injectable Market, By Application
      - Facial Line Correction
      - Lip Augmentation
      - Face Lift
      - Acne Scar Treatment
      - Lipoatrophy Treatment
      - Others
    - Norway Facial Injectable Market, By End-use
      - MedSpas
      - Dermatology Clinics
      - Hospitals
- Asia Pacific
  - Asia Pacific Facial Injectable Market, By Product
    - Collagen & PMMA Microspheres
    - Hyaluronic Acid (HA)
    - Botulinum Toxin Type A
    - Calcium Hydroxylapatite (CaHA)
    - Poly-L-lactic Acid (PLLA)
    - Others
  - Asia Pacific Facial Injectable Market, By Application
    - Facial Line Correction
    - Lip Augmentation
    - Face Lift
    - Acne Scar Treatment
    - Lipoatrophy Treatment
    - Others
  - Asia Pacific Facial Injectable Market, By End-use
    - MedSpas
    - Dermatology Clinics
    - Hospitals
  - Japan
    - Japan Facial Injectable Market, By Product
      - Collagen & PMMA Microspheres
      - Hyaluronic Acid (HA)
      - Botulinum Toxin Type A
      - Calcium Hydroxylapatite (CaHA)
      - Poly-L-lactic Acid (PLLA)
      - Others
    - Japan Facial Injectable Market, By Application
      - Facial Line Correction
      - Lip Augmentation
      - Face Lift
      - Acne Scar Treatment
      - Lipoatrophy Treatment
      - Others
    - Japan Facial Injectable Market, By End-use
      - MedSpas
      - Dermatology Clinics
      - Hospitals
  - China
    - China Facial Injectable Market, By Product
      - Collagen & PMMA Microspheres
      - Hyaluronic Acid (HA)
      - Botulinum Toxin Type A
      - Calcium Hydroxylapatite (CaHA)
      - Poly-L-lactic Acid (PLLA)
      - Others
    - China Facial Injectable Market, By Application
      - Facial Line Correction
      - Lip Augmentation
      - Face Lift
      - Acne Scar Treatment
      - Lipoatrophy Treatment
      - Others
    - China Facial Injectable Market, By End-use
      - MedSpas
      - Dermatology Clinics
      - Hospitals
  - India
    - India Facial Injectable Market, By Product
      - Collagen & PMMA Microspheres
      - Hyaluronic Acid (HA)
      - Botulinum Toxin Type A
      - Calcium Hydroxylapatite (CaHA)
      - Poly-L-lactic Acid (PLLA)
      - Others
    - India Facial Injectable Market, By Application
      - Facial Line Correction
      - Lip Augmentation
      - Face Lift
      - Acne Scar Treatment
      - Lipoatrophy Treatment
      - Others
    - India Facial Injectable Market, By End-use
      - MedSpas
      - Dermatology Clinics
      - Hospitals
  - Thailand
    - Thailand Facial Injectable Market, By Product
      - Collagen & PMMA Microspheres
      - Hyaluronic Acid (HA)
      - Botulinum Toxin Type A
      - Calcium Hydroxylapatite (CaHA)
      - Poly-L-lactic Acid (PLLA)
      - Others
    - Thailand Facial Injectable Market, By Application
      - Facial Line Correction
      - Lip Augmentation
      - Face Lift
      - Acne Scar Treatment
      - Lipoatrophy Treatment
      - Others
    - Thailand Facial Injectable Market, By End-use
      - MedSpas
      - Dermatology Clinics
      - Hospitals
  - South Korea
    - South Korea Facial Injectable Market, By Product
      - Collagen & PMMA Microspheres
      - Hyaluronic Acid (HA)
      - Botulinum Toxin Type A
      - Calcium Hydroxylapatite (CaHA)
      - Poly-L-lactic Acid (PLLA)
      - Others
    - South Korea Facial Injectable Market, By Application
      - Facial Line Correction
      - Lip Augmentation
      - Face Lift
      - Acne Scar Treatment
      - Lipoatrophy Treatment
      - Others
    - South Korea Facial Injectable Market, By End-use
      - MedSpas
      - Dermatology Clinics
      - Hospitals
  - Australia
    - Australia Facial Injectable Market, By Product
      - Collagen & PMMA Microspheres
      - Hyaluronic Acid (HA)
      - Botulinum Toxin Type A
      - Calcium Hydroxylapatite (CaHA)
      - Poly-L-lactic Acid (PLLA)
      - Others
    - Australia Facial Injectable Market, By Application
      - Facial Line Correction
      - Lip Augmentation
      - Face Lift
      - Acne Scar Treatment
      - Lipoatrophy Treatment
      - Others
    - Australia Facial Injectable Market, By End-use
      - MedSpas
      - Dermatology Clinics
      - Hospitals
- Latin America
  - Latin America Facial Injectable Market, By Product
    - Collagen & PMMA Microspheres
    - Hyaluronic Acid (HA)
    - Botulinum Toxin Type A
    - Calcium Hydroxylapatite (CaHA)
    - Poly-L-lactic Acid (PLLA)
    - Others
  - Latin America Facial Injectable Market, By Application
    - Facial Line Correction
    - Lip Augmentation
    - Face Lift
    - Acne Scar Treatment
    - Lipoatrophy Treatment
    - Others
  - Latin America Facial Injectable Market, By End-use
    - MedSpas
    - Dermatology Clinics
    - Hospitals
  - Brazil
    - Brazil Facial Injectable Market, By Product
      - Collagen & PMMA Microspheres
      - Hyaluronic Acid (HA)
      - Botulinum Toxin Type A
      - Calcium Hydroxylapatite (CaHA)
      - Poly-L-lactic Acid (PLLA)
      - Others
    - Brazil Facial Injectable Market, By Application
      - Facial Line Correction
      - Lip Augmentation
      - Face Lift
      - Acne Scar Treatment
      - Lipoatrophy Treatment
      - Others
    - Brazil Facial Injectable Market, By End-use
      - MedSpas
      - Dermatology Clinics
      - Hospitals
  - Mexico
    - Mexico Facial Injectable Market, By Product
      - Collagen & PMMA Microspheres
      - Hyaluronic Acid (HA)
      - Botulinum Toxin Type A
      - Calcium Hydroxylapatite (CaHA)
      - Poly-L-lactic Acid (PLLA)
      - Others
    - Mexico Facial Injectable Market, By Application
      - Facial Line Correction
      - Lip Augmentation
      - Face Lift
      - Acne Scar Treatment
      - Lipoatrophy Treatment
      - Others
    - Mexico Facial Injectable Market, By End-use
      - MedSpas
      - Dermatology Clinics
      - Hospitals
  - Argentina
    - Argentina Facial Injectable Market, By Product
      - Collagen & PMMA Microspheres
      - Hyaluronic Acid (HA)
      - Botulinum Toxin Type A
      - Calcium Hydroxylapatite (CaHA)
      - Poly-L-lactic Acid (PLLA)
      - Others
    - Argentina Facial Injectable Market, By Application
      - Facial Line Correction
      - Lip Augmentation
      - Face Lift
      - Acne Scar Treatment
      - Lipoatrophy Treatment
      - Others
    - Argentina Facial Injectable Market, By End-use
      - MedSpas
      - Dermatology Clinics
      - Hospitals
- MEA
  - MEA Facial Injectable Market, By Product
    - Collagen & PMMA Microspheres
    - Hyaluronic Acid (HA)
    - Botulinum Toxin Type A
    - Calcium Hydroxylapatite (CaHA)
    - Poly-L-lactic Acid (PLLA)
    - Others
  - MEA Facial Injectable Market, By Application
    - Facial Line Correction
    - Lip Augmentation
    - Face Lift
    - Acne Scar Treatment
    - Lipoatrophy Treatment
    - Others
  - MEA Facial Injectable Market, By End-use
    - MedSpas
    - Dermatology Clinics
    - Hospitals
  - South Africa
    - South Africa Facial Injectable Market, By Product
      - Collagen & PMMA Microspheres
      - Hyaluronic Acid (HA)
      - Botulinum Toxin Type A
      - Calcium Hydroxylapatite (CaHA)
      - Poly-L-lactic Acid (PLLA)
      - Others
    - South Africa Facial Injectable Market, By Application
      - Facial Line Correction
      - Lip Augmentation
      - Face Lift
      - Acne Scar Treatment
      - Lipoatrophy Treatment
      - Others
    - South Africa Facial Injectable Market, By End-use
      - MedSpas
      - Dermatology Clinics
      - Hospitals
  - Saudi Arabia
    - Saudi Arabia Facial Injectable Market, By Product
      - Collagen & PMMA Microspheres
      - Hyaluronic Acid (HA)
      - Botulinum Toxin Type A
      - Calcium Hydroxylapatite (CaHA)
      - Poly-L-lactic Acid (PLLA)
      - Others
    - Saudi Arabia Facial Injectable Market, By Application
      - Facial Line Correction
      - Lip Augmentation
      - Face Lift
      - Acne Scar Treatment
      - Lipoatrophy Treatment
      - Others
    - Saudi Arabia Facial Injectable Market, By End-use
      - MedSpas
      - Dermatology Clinics
      - Hospitals
  - UAE
    - UAE Facial Injectable Market, By Product
      - Collagen & PMMA Microspheres
      - Hyaluronic Acid (HA)
      - Botulinum Toxin Type A
      - Calcium Hydroxylapatite (CaHA)
      - Poly-L-lactic Acid (PLLA)
      - Others
    - UAE Facial Injectable Market, By Application
      - Facial Line Correction
      - Lip Augmentation
      - Face Lift
      - Acne Scar Treatment
      - Lipoatrophy Treatment
      - Others
    - UAE Facial Injectable Market, By End-use
      - MedSpas
      - Dermatology Clinics
      - Hospitals
  - Kuwait
    - Kuwait Facial Injectable Market, By Product
      - Collagen & PMMA Microspheres
      - Hyaluronic Acid (HA)
      - Botulinum Toxin Type A
      - Calcium Hydroxylapatite (CaHA)
      - Poly-L-lactic Acid (PLLA)
      - Others
    - Kuwait Facial Injectable Market, By Application
      - Facial Line Correction
      - Lip Augmentation
      - Face Lift
      - Acne Scar Treatment
      - Lipoatrophy Treatment
      - Others
    - Kuwait Facial Injectable Market, By End-use
      - MedSpas
      - Dermatology Clinics
      - Hospitals

Facial Injectable Market Dynamics

Drivers: Growing Aging Population

The facial injectable market is being propelled by the growing global elderly population. As more people age, there is an increasing demand for cosmetic solutions to maintain a youthful look and combat signs of aging. This has resulted in a significant rise in the demand for botulinum toxin and facial injectables that effectively address wrinkles, fine lines, and other age-related issues. Australia’s 2023 Intergenerational Report predicts that by 2050, the population aged between 65 and 84 years will more than double, and those aged 85 and above will quadruple. This demographic shift is leading to an increase in specialized clinics catering to the elderly. In New Zealand, the aging population is also having a substantial impact on the market. The country’s projected annual population growth is between 0.5% and 1.2%. This growth is bolstering the expansion of specialized cosmetic clinics and medical spas focusing on anti-aging treatments. This demographic change is anticipated to stimulate the creation of innovative procedures tailored to the needs of the aging population, including facial injectables. This trend is fostering a conducive environment for the market to flourish and effectively cater to the escalating demand.

Drivers: Increasing Awareness And Acceptance Of Aesthetic Treatments

The market is experiencing remarkable growth due to the rising awareness and acceptance of aesthetic treatments. As societal attitudes towards cosmetic procedures evolve, there is an increasing focus on physical appearance and self-care. Individuals are becoming more proactive, informed, and knowledgeable about using facial injectables to enhance their looks and address cosmetic issues. Moreover, the launch of various insurance schemes for aesthetic and cosmetic procedures has led to a surge in the awareness and acceptance of facial injectables, propelling the market growth. For example, Hamilton Fraser, a UK-based insurance company, offers coverage for a wide array of aesthetic procedures, including laser treatments, dermal fillers, chemical peels, and botulinum toxin. Social media significantly influences millennials’ purchasing decisions. Peer recommendations have a substantial impact, with approximately 71% of individuals more likely to purchase a product or service online if it is promoted by others, as per HubSpot’s 2019 statistics. Interestingly, a small percentage of influencers dominate the majority of social media referral branding. Forbes estimates that 5% of influencers endorsing products account for 45% of social impact. Therefore, maintaining ongoing interaction with clients is crucial when a business promotes its products on social media channels.

Restrains: Regulatory Constraints

The facial injectable market is anticipated to encounter substantial challenges due to strict regulatory restrictions. Regulatory bodies such as the Therapeutic Goods Administration (TGA) in Australia, Medsafe in New Zealand, and other key national regulators have set rigorous guidelines to ensure patient safety and monitor product usage. Compliance with these regulations necessitates comprehensive documentation, approvals, testing, and ongoing monitoring. This process could pose an entry barrier to this market, particularly for smaller companies with limited resources. In Australia, the lack of recognition for ‘cosmetic surgery’ as a specialized field and the absence of protection for the title ‘cosmetic surgeon’ under the Health Practitioner Regulation Law present additional regulatory obstacles. To address this, in September 2022, the Australian Health Practitioner Regulation Agency (Ahpra) and the Medical Board of Australia initiated an external review to address patient safety issues and reinforce the regulation of industry practitioners. The review aimed to establish checks and balances, with a focus on enhancing communication and collaboration among state and territory authorities involved in the existing regulatory system. Following the review process, in September 2023, Ahpra announced that new guidelines with strict practice standards and new advertising rules would be introduced by the end of 2023 or early 2024.

What Does This Report Include?

This section will provide insights into the contents included in this facial injectable market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Facial injectable market qualitative analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Facial injectable market quantitative analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.